Catalent Indiana
FDA Rejects Scholar Rock’s SMA Drug Due to Catalent Indiana Manufacturing Issues
FDA; Scholar Rock; Apitegromab; SMA; Spinal Muscular Atrophy; Catalent Indiana; Complete Response Letter; Manufacturing issues; Drug approval
Actionable Insights Powered by AI
FDA; Scholar Rock; Apitegromab; SMA; Spinal Muscular Atrophy; Catalent Indiana; Complete Response Letter; Manufacturing issues; Drug approval